| Product Code: ETC7551934 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India primary biliary cholangitis market import shipments exhibited a steady expansion from 2020 to 2024, with a CAGR of 5.3%. However, there was a slight slowdown in growth between 2023 and 2024, with the growth rate decreasing to 1.2%. Despite this minor dip, the overall trend shows a positive momentum in market growth.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Primary Biliary Cholangitis Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Primary Biliary Cholangitis Market Revenues & Volume, 2021 & 2031F |
3.3 India Primary Biliary Cholangitis Market - Industry Life Cycle |
3.4 India Primary Biliary Cholangitis Market - Porter's Five Forces |
3.5 India Primary Biliary Cholangitis Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 India Primary Biliary Cholangitis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 India Primary Biliary Cholangitis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Primary Biliary Cholangitis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 India Primary Biliary Cholangitis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Primary Biliary Cholangitis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Rising prevalence of primary biliary cholangitis (PBC) in India |
4.2.2 Increased awareness about liver diseases and early diagnosis |
4.2.3 Technological advancements in the healthcare sector leading to better treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for PBC treatment in India |
4.3.2 High cost associated with advanced treatment options for PBC |
4.3.3 Lack of skilled healthcare professionals specializing in treating PBC |
5 India Primary Biliary Cholangitis Market Trends |
6 India Primary Biliary Cholangitis Market, By Types |
6.1 India Primary Biliary Cholangitis Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 India Primary Biliary Cholangitis Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 India Primary Biliary Cholangitis Market Revenues & Volume, By Liver Transplantation, 2021- 2031F |
6.1.4 India Primary Biliary Cholangitis Market Revenues & Volume, By Drug Therapy, 2021- 2031F |
6.1.5 India Primary Biliary Cholangitis Market Revenues & Volume, By Ursodeoxycholic acid (UDCA), 2021- 2031F |
6.1.6 India Primary Biliary Cholangitis Market Revenues & Volume, By Obeticholic acid, 2021- 2031F |
6.1.7 India Primary Biliary Cholangitis Market Revenues & Volume, By Fibrates, 2021- 2031F |
6.1.8 India Primary Biliary Cholangitis Market Revenues & Volume, By Budesonide, 2021- 2031F |
6.2 India Primary Biliary Cholangitis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 India Primary Biliary Cholangitis Market Revenues & Volume, By FibroScan, 2021- 2031F |
6.2.3 India Primary Biliary Cholangitis Market Revenues & Volume, By Blood Tests, 2021- 2031F |
6.2.4 India Primary Biliary Cholangitis Market Revenues & Volume, By Cholesterol Test, 2021- 2031F |
6.2.5 India Primary Biliary Cholangitis Market Revenues & Volume, By Antibody Test, 2021- 2031F |
6.2.6 India Primary Biliary Cholangitis Market Revenues & Volume, By Liver Test, 2021- 2031F |
6.2.7 India Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Primary Biliary Cholangitis Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Primary Biliary Cholangitis Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Primary Biliary Cholangitis Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Primary Biliary Cholangitis Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 India Primary Biliary Cholangitis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Primary Biliary Cholangitis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 India Primary Biliary Cholangitis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 India Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Primary Biliary Cholangitis Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Primary Biliary Cholangitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Primary Biliary Cholangitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 India Primary Biliary Cholangitis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 India Primary Biliary Cholangitis Market Revenues & Volume, By Others, 2021- 2031F |
7 India Primary Biliary Cholangitis Market Import-Export Trade Statistics |
7.1 India Primary Biliary Cholangitis Market Export to Major Countries |
7.2 India Primary Biliary Cholangitis Market Imports from Major Countries |
8 India Primary Biliary Cholangitis Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis |
8.2 Number of PBC patients receiving proper treatment |
8.3 Patient satisfaction with healthcare services for PBC |
9 India Primary Biliary Cholangitis Market - Opportunity Assessment |
9.1 India Primary Biliary Cholangitis Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 India Primary Biliary Cholangitis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 India Primary Biliary Cholangitis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Primary Biliary Cholangitis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 India Primary Biliary Cholangitis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Primary Biliary Cholangitis Market - Competitive Landscape |
10.1 India Primary Biliary Cholangitis Market Revenue Share, By Companies, 2024 |
10.2 India Primary Biliary Cholangitis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here